SGT-501

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameSGT-501
Drug Alias NameSGT-501
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCalsequestrin-2 gene transferenceRyanodine receptor 2 gene transference
TargetsCalsequestrin-2Ryanodine receptor 2
Therapy Area/IndicationsTachycardia, Ventricular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSolid Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesSolid Biosciences IncSolid Biosciences Llc
Inactive CompaniesN/A
Active IndicationsTachycardia, Ventricular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A